期刊文献+

不同胰岛素抵抗状态肥胖女性体脂肪分布特点及胰岛β细胞功能变化 被引量:3

Characteristics of body fat distribution and changes of isletβ-cell function among obese women with different insulin resistance status
原文传递
导出
摘要 目的探讨不同胰岛素抵抗状态的非糖尿病肥胖女性体脂肪分布特点及胰岛β细胞功能变化。方法 94例总体脂肪含量≥35%的肥胖女性,采用双能X线骨密度仪检测体成分,计算总体及躯干、上肢、下肢等部位脂肪含量、各部位-总体脂肪比。利用静脉葡萄糖耐量试验计算胰岛素曲线下面积(AUC_(ins))、胰岛素急性分泌时相(AIR)和稳态模型β细胞功能指数(HOMA2-%β)、胰岛素敏感指数(HOMA2-%S)、胰岛素抵抗指数(HOMA2-IR)。按HOMA2-IR值四分位间距分组,比较各组基本临床特征、胰岛β细胞功能、体脂肪含量及分布情况,分析与HOMA2-IR相关的因素;比较不同年龄段上述部分指标的差异。结果随着HOMA2-IR增加,躯干脂肪含量、躯干-总体脂肪比、HOMA2-%β、AUC_(ins)、AIR及葡萄糖耐量试验2h血糖(2hPG)均呈增加趋势,下肢-总体脂肪比和HOMA2-%S则呈减少趋势。HOMA2-IR与躯干脂肪含量、躯干-总体脂肪比及2hPG呈正相关(r=0.358、0.205、0.225,均P<0.05),与年龄、下肢-总体脂肪比呈负相关(r=-0.216、-0.313,均P<0.05)。与年龄>30岁女性比较,≤30岁肥胖女性总体、躯干及四肢脂肪含量较高(均P<0.05),有较高的HOMA2-%β、HOMA2-IR、AIR、AUC_(ins)水平和较低的HOMA2-%S(均P<0.05)。结论非糖尿病的肥胖女性,在高胰岛素抵抗状态下,更趋向于躯干脂肪的堆积及下肢脂肪分布的减少,并伴有胰岛β细胞功能的代偿。 AIM To explore the characteristics of body fat distribution and the changes of islet β-cell function among non-diabetic obese women with different insulin resistance (IR) status. METHODS Dualenergy X-ray absorptiometry (DEXA) was applied to measure the body fat content of 94 obese women whose total body fat content was greater than 35% without exception. Total body, trunk, arm and leg fat content, fat mass in different parts-total fat mass ratio were calculated. Area under the curve of insulin (AUCi.s) , acute insulin response (AIR), homeostasis model assessment of β-cell function index (HOMA2-%β), homeostasis model assessment of insulin sensitivity index (HOMA2-% S) and homeostasis model assessment of insulin resistance index (HOMA2-IR) were calculated by using intravenous glucose tolerance test (IVGTF) . The patients were assigned into four groups based on the quartile of HOMA2-IR to compare basic clinical characteristics, islet β-cell function, body fat content and distribution of each group, and investigate the related factors of HOMA2-IR. The differences of the above mentioned indices in different age were identified. RESULTS With the elevation of HOMA2-IR, the trunk fat content, trunk fat-total fat ratio, HOMA2-% β, AUCins, AIR and 2 hours glucose of glucose tolerance test (2hPG) were increased. In contrast, leg fat-total ratio fat and HOMA2-%S were decreased. HOMA2-IR was positively correlated with trunk fat content, trunk fat-total ratio body fat and 2hPG (r = 0.358, 0.205, 0.225, all P 〈 0.05). However, it showed a negative association with age and leg fat-total fat ratio (r = -0.216, -0.313, all P 〈 0.05). The obese women who were younger than 30 years old maintained higher total body, trunk fat content and limb fat content (all P 〈 0.05), as well as higher HOMA2-%β, HOMA2-IR, AIR, AUCins relatively and lower HOMA2-%S (all P 〈 0.05) when compared with the subjects older than 30 years old. CONCLUSION Among non-diabetic obese women with high insulin resistance status, the accumulation of trunk fat and reduction of leg fat distribution are more likely to occur, and the compensatory of islet β-cell function can also be identified.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2011年第6期444-448,共5页 Chinese Journal of New Drugs and Clinical Remedies
基金 福建省教育厅科技项目(JA05263)
关键词 肥胖症 体脂分布 胰岛素抗药性 obesity body fat distribution insulin resistance
  • 相关文献

参考文献16

  • 1HO-PHAM LT, LAI TQ, NGUYEN ND, et al. Similarity in pereent body fat between white and Vietnamese women: implication for a universal definition of obesity[J]. Obesity (Silver Spring), 2010, 18(6) : 1242-1246.
  • 2严孙杰,沈喜妹,颜晓芳,易如海,吴佩文,杨立勇,张松菁.正常糖代谢肥胖女性体成分改变及β细胞功能分析[J].中华内分泌代谢杂志,2009,25(1):52-55. 被引量:11
  • 3GASTALDELLI A, CUSI K, PETTITI M, et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects [J]. Gastroenterology, 2007, 133(2) : 496-506.
  • 4World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee [J]. World Health Organ Tech Rep Ser, 1995, 854: 1-452.
  • 5SECOR SM, NAGY TR. Non-invasive measure of body composition of snakes using dual-energy X-ray absorptiometry [J]. Comp Biochem Physiol A Mol Integr Physiol, 2003, 136(2): 379-389.
  • 6WALLACE TM, LEVY JC, MATYHEWS DR. Use and abuse of HOMA modeling[J]. Diabetes Care, 2004, 27(6) : 1487-1495.
  • 7BOORSMA W, SNIJDER MB, NIJPELS G, et al. Body composition, insulin sensitivity, and cardiovascular disease profile in healthy Europeans[J]. Obesity, 2008, 16(12) : 2696-2701.
  • 8BUEMANN B, SORENSEN TI, PEDERSEN O, et al. Lowerbody fat mass as an independent marker of insulin sensitivity--the role of adiponectin[J]. Int J Obes (Lond), 2005, 29(6): 624 - 631.
  • 9严孙杰,沈喜妹,杨立勇,张松菁,易如海,顔晓芳.不同糖代谢状态肥胖女性体脂对胰岛素敏感性的影响[J].福建医科大学学报,2009,43(6):479-482. 被引量:4
  • 10JENSEN MD. Role of body fat distribution and the metabolie complications of obesity [J]. J Clin Endocrinol Metab, 2008, 93 (11 Suppl 1 ) : S57-S63.

二级参考文献26

  • 1Snijder MB, Visser M, Dekker JM, et al. The prediction of visceral fat by dual-energy X-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry. Int J Obes Relat Metab Disord, 2002,26:984-993.
  • 2Lee K, Lee S, Kim YJ, et al. Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women. Nutrition, 2008,24:625-631.
  • 3Rhodes CJ. Type 2 diabetes-a matter of β-cell life and death? Science, 2005,307:380-384.
  • 4Asghar Z, Yau D, Chan F, et al. Insulin resistance causes increased beta-cell mass but defective glucose-stimuiated insulin secretion in a murine model of type 2 diabetes. Diabetologia, 2006,49:90-99.
  • 5Pick A, Clark J, Kubstrup C, et al. Role of apoptosis in failure of β- cell mass compensation for insulin resistance and β-cell defects in the male Zueker diabetic fatty rat. Diabetes, 1998,47:358-364.
  • 6Wagenknecht LE, Langefeld CD, Scherzinger AL, et al. Insulin sensitivity, insulin secretion, and abdominal fat. The Insulin Resistance Atherosclerosis Study (IRAS) family study. Diabetes, 2003,52:2490-2496.
  • 7He M, Tan KCB, Li ETS, et al. Body fat determination by dual energy X-ray absorptiometry and its relation to body mass index and waist circumference in Hong Kong Chinese. Int J Obes Relat Metab Disord, 2001,25 : 748-752.
  • 8Kim SK, Kim HJ, Hur KY, et al. Visceral fat thickness measured by uhrasonography can estimate not only visceral obesity but also risks of cardiovascular and metabolic diseases. Am J Clin Nutr, 2004,79:593- 599.
  • 9Goran MI, Bergman RN, Gower BA. Influence of total vs. visceral fat on insulin action and secretion in African American and white children. Obes Res, 2001,9:423431.
  • 10Aniana M, Sandeep S, Deepa R, et al. Visceral and central abdominal fat and anthropometry in relation to diabetes in Asia Indians. Diabetes Care, 2004,27:2948-2953.

共引文献12

同被引文献17

  • 1GIBSON CD, KARMALLY W, MCMAHON DJ, et ol. Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults[J]. Diabetes Obes Metab, 2012, 14(4) : 335-340.
  • 2GARCIA-TORNADU I, ORNSTEIN AM, CHAMSON-REIG A, et al. Disruption of the dopamine D2 receptor impairs insulin secretion and causes glucose intolerance[J]. Endocrinology, 2010, 151(4): 1441-1450.
  • 3dos SANTOS SILVA CM, BARBOSA FR, LIMA GA, et ol. BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists[J]. Obesity, 2011, 19(4) : 800-805.
  • 4HOLT RIG, PEVELER RC. Antipsychotics and hyperprolactin- aemia: mechanisms, consequences and management[J]. Clinical Endocrinology, 2011, 74(2): 141-147.
  • 5SCHERNTHANER G, PTAGER R, PUNZENGRUBER C, et ol. Severe hyperprolactinemia is associated with decreased insulin binding in vitro and insulin resistance in vivo[J]. Diabetologia, 1985, 28(3): 138-142.
  • 6REIS FM, REIS AM, COIMBRA CC. Effects of hyperprolactin- aemia on glucose tolerance and insulin release in male and female rats[J]. J Endocrinol, 1997, 153(3): 423-428.
  • 7SCHMID C, GOEDE DL, HAUSER RS, et al. Increased prevalence of high body mass index in patients presenting with pituitary tumours: severe obesity in patients with macroprolac- tinoma[J]. Swiss Medical Weekly, 2006, 136 ( 15 ) : 254-258.
  • 8BAHCECI M, TUZCU A, BAHCECI S, et al. Is hyperprolac- tinemia associated with insulin resistance in non- obese patients with polycystic ovary syndrome?[J]. J Endocrinol Invest, 2003, 26 (7) : 655-659.
  • 9曹洪民,何维,肖存利,雷小星,秦卫红,魏时懿,卢新志,张颖.精神分裂症患者胰岛素分泌异常的影响因素分析[J].北京医学,2008,30(6):371-372. 被引量:4
  • 10丁晓东,范建高.非酒精性肝脂肪变性和脂肪性肝炎的发生机制[J].现代消化及介入诊疗,2009,14(4):237-242. 被引量:13

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部